Jordan Stuart, US equities portfolio manager, Federated Hermes, discusses why after a slump in 2022, biotech stocks especially small caps are attractive options to diversify into for their uncorrelated traits.
Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek
3,938 clip(s)
Mind Your Business: How can Microsoft be the “Copilot” SMEs need to navigate the AI era?
Bigger Pic: Xi-Biden meeting takeaways for investors
Morning Shot: Why is multilateral cooperation key in fostering growth amid potential global trade wars in a new Trump era?